icine, the Chief Data Officer of the Department of 
Health and Human Services, and the Chief Artificial 
Intelligence Officer of the Department of Health and 
Human Services, shall convene an expert panel to 
consider and make recommendations regarding the 
types, sources, and availability of data needed to ac-
celerate diagnostic safety and quality research, train-
ing, and measure development as specified in section 
918, including— 
‘‘(A) demographic data; 
‘‘(B) the specificity, interoperability, and 
socio-technical aspects of electronic vocabularies 
and ontologies related to presenting symptoms, 
chief complaints, and the status of diagnosis 
(such as tentative, working, or confirmed); and 
‘‘(C) the development and use of symptom- 
based clinical registries. Such panel shall con-
sider enhanced data capabilities that are nec-
essary to support both research and improve-
ment of diagnostic safety and quality.’’. 
SEC. 6. INTERAGENCY COUNCIL ON IMPROVING DIAGNOSIS 
IN HEALTH CARE. 
(a) ESTABLISHMENT.—The Secretary of Health and 
Human Services (in this section referred to as the ‘‘Sec-
retary’’) shall establish within the Office of the Secretary 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
an interagency council to be known as the Interagency 
Council on Improving Diagnosis in Health Care (referred 
to in this section as the ‘‘Council’’). 
(b) OBJECTIVES.—The objectives of the Council shall 
be the following: 
(1) Enhance the quality, appropriateness, and 
effectiveness of diagnosis in health care through— 
(A) the establishment and support of a 
broad base of scientific research; 
(B) the dissemination and implementation 
of the results of such research; and 
(C) the promotion of improvements in clin-
ical and health system practices. 
(2) Identify and eliminate systemic barriers to 
supporting research in improving diagnosis in health 
care. 
(3) Identify knowledge gaps, research and data 
needs, and opportunities congruent with agency mis-
sions to strengthen the clinical and translational re-
search pipeline to improve diagnostic safety and 
quality, including potential collaborative research ini-
tiatives among 2 or more agencies, offices, institutes, 
or centers within the Department of Health and 
Human Services or other Federal agencies or offices. 
(c) MEMBERSHIP.— 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
(1) CHAIRPERSON.—The Director of the Agen-
cy for Healthcare Research and Quality (or the Di-
rector’s designee) shall be the Chairperson of the 
Council. 
(2) MEMBERS.— 
(A) IN
GENERAL.—In addition to the 
Chairperson, the Council shall be comprised of 
the following: 
(i) At least 1 designee from each of 
the following, appointed by the head of the 
applicable department or agency: 
(I) The Centers for Disease Con-
trol and Prevention. 
(II) The Centers for Medicare & 
Medicaid Services. 
(III) The Department of Vet-
erans Affairs. 
(IV) The Congressionally Di-
rected Medical Research Program of 
the Department of Defense. 
(V) The Office of the National 
Coordinator for Health Information 
Technology. 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
(VI) The Office of the Chief 
Data Officer of the Department of 
Health and Human Services. 
(VII) The Office of the Chief Ar-
tificial Intelligence Officer of the De-
partment of Health and Human Serv-
ices. 
(VIII) The Center for Devices 
and Radiological Health of the Food 
and Drug Administration. 
(ii) Designees from the National Insti-
tutes of Health, including a least 1 des-
ignee from each of the following: 
(I) The National Cancer Insti-
tute. 
(II) The National Center for Ad-
vancing Translational Sciences. 
(III) The National Institute of 
Allergy and Infectious Diseases. 
(IV) The National Heart, Lung, 
and Blood Institute. 
(V) The National Institute of 
Neurological Disorders and Stroke. 
(VI) The National Library of 
Medicine. 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
(VII) The National Institute on 
Minority Health and Health Dispari-
ties. 
(VIII) The National Institute of 
Nursing Research. 
(IX) The Eunice Kennedy Shriv-
er National Institute of Child Health 
and Human Development. 
(iii) Designees from such other na-
tional research institutes and national cen-
ters as may be appropriate, as determined 
by the Director of the National Institutes 
of Health. 
(B) ADDITIONAL MEMBERS.—In addition 
to the designees under subparagraph (A), the 
Council may include such other designees from 
Federal departments or agencies as the Chair-
person of the Council determines appropriate. 
(C) DESIGNATION.—A person appointed to 
the Council as a designee shall be a senior offi-
cial or employee of the department or agency 
whose responsibilities and subject matter exper-
tise are relevant to the Council’s objectives list-
ed in subsection (b), as determined by the des-
ignating official. 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
(d) STRATEGIC PLAN; REPORTS.— 
(1) STRATEGIC FEDERAL PLAN TO IMPROVE DI-
AGNOSIS
IN
HEALTH
CARE.—Not later than 18 
months after the date of enactment of this Act, the 
Council shall develop, submit to the Secretary and 
Congress, and make publicly available a strategic 
plan, to be known as the Strategic Federal Plan to 
Improve Diagnosis, that, consistent with the objec-
tives listed in subsection (b)— 
(A) identifies coordinated opportunities to 
enhance scientific research and reduce systemic 
barriers in order to improve diagnosis in health 
care; and 
(B) includes legislative and administrative 
policy recommendations, including opportunities 
to remove barriers to, and enhance, inter-agen-
cy coordination in the planning, conduct, and 
funding of, such research. 
(2) REPORTS TO CONGRESS.—Not later than 
July 31 of every odd-numbered year beginning with 
the first such year after the date of submission of 
the first Strategic Federal Plan to Improve Diag-
nosis under paragraph (1), the Council shall pre-
pare, submit to the Secretary and Congress, and 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
make publicly available an updated Strategic Fed-
eral Plan to Improve Diagnosis that includes— 
(A) such updates as the Council deter-
mines to be appropriate; 
(B) information on the overall progress of 
the Federal Government in reducing barriers to 
research on, and supporting projects to im-
prove, diagnosis in health care; and 
(C) legislative and administrative policy 
recommendations, including addressing any 
needs for greater legislative authority to meet 
the objectives listed in subsection (b). 
(e) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there are authorized to be appropriated 
$1,500,000 for each of fiscal years 2025 through 2029. 
SEC. 7. NATIONAL ACADEMIES REPORT. 
(a) IN GENERAL.—The Director of the Agency for 
Healthcare Research and Quality shall seek to enter into 
a contract with the National Academies of Sciences, Engi-
neering, and Medicine under which such National Acad-
emies conducts a study and issues a report on disparities 
in diagnostic safety and quality that— 
(1) identifies what is known about the burden 
and causes of such disparities, including racial, eth-
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS
nic, socioeconomic, age, gender, geography, language 
proficiency, and intersectional interactions; and 
(2) includes recommendations on specific ac-
tions that policymakers, researchers, clinicians, and 
other stakeholders can take to eliminate such bur-
dens. 
(b) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
$1,500,000 for fiscal year 2025, to remain available until 
expended. 
Æ 
VerDate Sep 11 2014 
01:20 Nov 16, 2024
Jkt 059200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6301
E:\BILLS\H10135.IH
H10135
ssavage on LAPJG3WLY3PROD with BILLS